|
Delayed
Nasdaq
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 05/06/2017 | |
David McIntyre
DFI | Director of Finance/CFO | 55 | 01/10/2016 |
Sonnie Kim
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Seth Harrison
CHM | Chairman | 65 | - |
| Director/Board Member | 73 | 01/09/2015 | |
David McIntyre
BRD | Director/Board Member | 55 | 01/10/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 0 | |
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | |
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | |
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | |
| +0.42% | +3.20% | +55.81% | +72.50% | 391B | |
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | |
| +1.12% | +4.52% | +34.76% | +58.24% | 307B | |
| +6.96% | +8.86% | +11.95% | +36.20% | 290B | |
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | |
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | |
| Average | +1.88% | +5.31% | +46.58% | +84.56% | 426.19B | |
| Weighted average by Cap. | +2.01% | +6.60% | +50.51% | +100.44% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- BBRX Stock
Select your edition
All financial news and data tailored to specific country editions
